About
The ability to live a longer, healthier life should be available to everyone (and their…
Articles by Garri
-
Take your first steps into the longevity community: Join us at ARDD
Take your first steps into the longevity community: Join us at ARDD
By Garri Zmudze
-
Women at the forefront of longevity: Celebrating and investing in an inclusive future
Women at the forefront of longevity: Celebrating and investing in an inclusive future
By Garri Zmudze
-
VCs and universities: Collaboration benefits us all
VCs and universities: Collaboration benefits us all
By Garri Zmudze
Activity
-
The all-star lineup at the Physics in Aging Biology workshop during the ARDD. Albert-Laszlo Barabasi among other scientists will look at how to study…
The all-star lineup at the Physics in Aging Biology workshop during the ARDD. Albert-Laszlo Barabasi among other scientists will look at how to study…
Liked by Garri Zmudze
-
Breaking: Utah-based Recursion acquires UK-based AI-drug discovery comapany Exscientia in arguably the largest AI in bio deal so far. Recursion…
Breaking: Utah-based Recursion acquires UK-based AI-drug discovery comapany Exscientia in arguably the largest AI in bio deal so far. Recursion…
Liked by Garri Zmudze
-
Less than 3 weeks till the start of the world’s leading conference in longevity space -- #ARDD2024! 🚀 Already traditional, the 11th Aging Research…
Less than 3 weeks till the start of the world’s leading conference in longevity space -- #ARDD2024! 🚀 Already traditional, the 11th Aging Research…
Shared by Garri Zmudze
Experience & Education
More activity by Garri
-
There is a lot of noise in AI Drug Discovery where some are hyping up this industry, some are anti-hyping. My view - there is NO AI Drug Discovery…
There is a lot of noise in AI Drug Discovery where some are hyping up this industry, some are anti-hyping. My view - there is NO AI Drug Discovery…
Liked by Garri Zmudze
-
With much of the research I've conducted in my precision oncology days being in glioma, it delights me to see the FDA approval of vorasidenib, an…
With much of the research I've conducted in my precision oncology days being in glioma, it delights me to see the FDA approval of vorasidenib, an…
Liked by Garri Zmudze
-
I am looking forward to speaking at the Entourage Accelerator by Gil Petersil in Florida next week. It's a great platform that brings together global…
I am looking forward to speaking at the Entourage Accelerator by Gil Petersil in Florida next week. It's a great platform that brings together global…
Liked by Garri Zmudze
-
Looking to create content in your language? 🗣 Choose any of the 13 different languages we already offer on our Engage platform. Would you like to…
Looking to create content in your language? 🗣 Choose any of the 13 different languages we already offer on our Engage platform. Would you like to…
Liked by Garri Zmudze
-
For those of you interested in the latest trends in medicine - check out this conference happening at Stanford University. We have an incredible line…
For those of you interested in the latest trends in medicine - check out this conference happening at Stanford University. We have an incredible line…
Liked by Garri Zmudze
-
It’s pretty cool to see DOG PPL INC., a project we’ve just backed via AniVC featured by Chrissy Teigen an American model and Instagram influencer…
It’s pretty cool to see DOG PPL INC., a project we’ve just backed via AniVC featured by Chrissy Teigen an American model and Instagram influencer…
Shared by Garri Zmudze
-
Cool news: Lantern Pharma Inc. (Nasdaq: LTRN) reports 86% clinical benefit in oncology clinical trial, for initial patient cohort. Dallas-based…
Cool news: Lantern Pharma Inc. (Nasdaq: LTRN) reports 86% clinical benefit in oncology clinical trial, for initial patient cohort. Dallas-based…
Liked by Garri Zmudze
-
IBI, the company beyond next generation products for tissue engineering and regenerative medicine is hiring at the Ticino Headquarter…
IBI, the company beyond next generation products for tissue engineering and regenerative medicine is hiring at the Ticino Headquarter…
Liked by Garri Zmudze
-
𝐃𝐨𝐧’𝐭 𝐰𝐚𝐢𝐭 𝐟𝐨𝐫 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬; 𝐂𝐫𝐞𝐚𝐭𝐞 𝐲𝐨𝐮𝐫 𝐨𝐰𝐧 Here is the observation after years of studying how VCs make…
𝐃𝐨𝐧’𝐭 𝐰𝐚𝐢𝐭 𝐟𝐨𝐫 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬; 𝐂𝐫𝐞𝐚𝐭𝐞 𝐲𝐨𝐮𝐫 𝐨𝐰𝐧 Here is the observation after years of studying how VCs make…
Liked by Garri Zmudze
-
As AI evolves, it is crucial for all stakeholders—from researchers and developers to policymakers and patients—to engage in ongoing dialogue about…
As AI evolves, it is crucial for all stakeholders—from researchers and developers to policymakers and patients—to engage in ongoing dialogue about…
Liked by Garri Zmudze
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More